Earnings Feed
Start Free
Home/Insiders/D'Adamio Anthony
DA
SEC Insider//CIK 0001835184

D'Adamio Anthony

CIK 00018351841 companyDURHAM, NC
SEC Profile

Transactions

48

Companies

1

Filings

14

CIK

0001835184

Recent Transactions

48 trades
  • Sale
    Bioventus Inc.$BVS

    Class A Common Stock

    2025-04-11$7.57/sh−2,958→ 131,416 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Restricted Stock Units

    2025-04-10−9,925→ 19,850 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Class A Common Stock

    2025-04-10+9,925→ 134,374 total
  • Sale
    Bioventus Inc.$BVS

    Class A Common Stock

    2025-03-17$9.75/sh−2,615→ 124,449 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Class A Common Stock

    2025-03-14+8,886→ 127,064 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Restricted Stock Units

    2025-03-14−8,886→ 8,886 total
  • Sale
    Bioventus Inc.$BVS

    Class A Common Stock

    2025-02-18$10.19/sh−4,380→ 118,178 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Class A Common Stock

    2025-02-15+12,980→ 122,558 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Restricted Stock Units

    2025-02-15−12,980→ 38,940 total
  • Sale
    Bioventus Inc.$BVS

    Class A Common Stock

    2024-12-23$10.53/sh−5,848→ 109,578 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Restricted Stock Units

    2024-12-20−19,850→ 0 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Class A Common Stock

    2024-12-20+19,850→ 115,426 total
  • Sale
    Bioventus Inc.$BVS

    Class A Common Stock

    2024-06-21$5.57/sh−5,904→ 95,576 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Class A Common Stock

    2024-06-20+19,850→ 101,480 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Restricted Stock Units

    2024-06-20−19,850→ 19,850 total
  • Sale
    Bioventus Inc.$BVS

    Class A Common Stock

    2024-06-17$5.84/sh−11,308→ 81,630 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Class A Common Stock

    2024-06-15+34,696→ 92,938 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Restricted Stock Units

    2024-06-15−34,696→ 0 total
  • Sale
    Bioventus Inc.$BVS

    Class A Common Stock

    2024-04-11$4.75/sh−3,054→ 58,242 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Class A Common Stock

    2024-04-10+9,925→ 61,296 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Restricted Stock Units

    2024-04-10−9,925→ 29,775 total
  • Award
    Bioventus Inc.$BVS

    Restricted Stock Units

    2024-03-15+51,920→ 51,920 total
  • Award
    Bioventus Inc.$BVS

    Restricted Stock Units

    2024-03-15+34,696→ 34,696 total
  • Award
    Bioventus Inc.$BVS

    Stock Option (Right to Buy)

    2024-03-15+120,000→ 120,000 total
  • Sale
    Bioventus Inc.$BVS

    Class A Common Stock

    2024-03-15$5.46/sh−3,125→ 51,371 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Class A Common Stock

    2024-03-14+8,886→ 54,496 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Restricted Stock Units

    2024-03-14−8,886→ 17,772 total
  • Award
    Bioventus Inc.$BVS

    Restricted Stock Units

    2023-06-20+39,700→ 39,700 total
  • Award
    Bioventus Inc.$BVS

    Stock Option (Right to Buy)

    2023-04-10+103,600→ 103,600 total
  • Award
    Bioventus Inc.$BVS

    Restricted Stock Units

    2023-04-10+39,700→ 39,700 total
  • Sale
    Bioventus Inc.$BVS

    Class A Common Stock

    2023-03-15$1.39/sh−3,409→ 45,610 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Class A Common Stock

    2023-03-14+8,887→ 49,019 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Restricted Stock Units

    2023-03-14−8,887→ 26,658 total
  • Sale
    Bioventus Inc.$BVS

    Class A Common Stock

    2022-04-04$11.19/sh−16,016→ 40,132 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Class A Common Stock

    2022-04-01+37,476→ 56,148 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Restricted Stock Units

    2022-04-01−37,476→ 0 total
  • Award
    Bioventus Inc.$BVS

    Restricted Stock Units

    2022-03-14+35,545→ 35,545 total
  • Award
    Bioventus Inc.$BVS

    Stock Option (Right to Buy)

    2022-03-14+96,133→ 96,133 total
  • Sale
    Bioventus Inc.$BVS

    Class A Common Stock

    2022-02-14$11.99/sh−1,294→ 18,672 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Class A Common Stock

    2022-02-11+4,400→ 19,966 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Restricted Stock Units

    2022-02-11−4,400→ 0 total
  • Tax Payment
    Bioventus Inc.$BVS

    Class A Common Stock

    2022-02-10$12.88/sh+6,599→ 15,566 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Class A Common Stock

    2022-02-10+21,165→ 22,165 total
  • Exercise/Conversion
    Bioventus Inc.$BVS

    Phantom Profit Units

    2022-02-10−21,165→ 0 total
  • Award
    Bioventus Inc.$BVS

    Restricted Stock Units

    2021-04-01+37,476→ 37,476 total
  • Award
    Bioventus Inc.$BVS

    Stock Options

    2021-04-01+9,500→ 9,500 total
  • Purchase
    Bioventus Inc.$BVS

    Common Stock

    2021-02-11$13.00/sh+1,000→ 1,000 total
  • Award
    Bioventus Inc.$BVS

    Restricted Stock Units

    2021-02-11+4,400→ 4,400 total

Companies

1

Recent Filings

14

Address

4721 EMPEROR BOULEVARD, SUITE 100

DURHAM, NC, 27703

View on SEC.gov